KTRA logo

Kintara Therapeutics (KTRA) Current Liabilities

Annual Current Liabilities

$2.26 M
-$823.00 K-26.70%

01 June 2024

KTRA Current Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Current Liabilities

$2.26 M
+$918.00 K+68.46%

01 June 2024

KTRA Quarterly Current Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

KTRA Current Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-26.7%-32.3%
3 y3 years-18.7%-24.7%
5 y5 years+9.2%+68.7%

KTRA Current Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years
5 y5 years
alltimeall time-43.4%-43.4%

Kintara Therapeutics Current Liabilities History

DateAnnualQuarterly
June 2024
$2.26 M(-26.7%)
$2.26 M(+68.5%)
Mar 2024
-
$1.34 M(-28.3%)
Dec 2023
-
$1.87 M(-43.9%)
Sept 2023
-
$3.34 M(+8.2%)
June 2023
$3.08 M(-22.8%)
$3.08 M(+10.5%)
Mar 2023
-
$2.79 M(-13.9%)
Dec 2022
-
$3.24 M(-7.9%)
Sept 2022
-
$3.52 M(-11.9%)
June 2022
$3.99 M(+43.5%)
$3.99 M(+23.1%)
Mar 2022
-
$3.24 M(-5.8%)
Dec 2021
-
$3.44 M(+14.6%)
Sept 2021
-
$3.00 M(+7.9%)
June 2021
$2.78 M(+3.9%)
$2.78 M(+9.8%)
Mar 2021
-
$2.53 M(-7.1%)
Dec 2020
-
$2.73 M(+14.1%)
Sept 2020
-
$2.39 M(-10.7%)
June 2020
$2.67 M(+29.2%)
$2.67 M(+93.6%)
Mar 2020
-
$1.38 M(+34.5%)
Dec 2019
-
$1.03 M(-23.3%)
Sept 2019
-
$1.34 M(-35.3%)
June 2019
$2.07 M(+26.3%)
$2.07 M(+72.8%)
Mar 2019
-
$1.20 M(-5.6%)
Dec 2018
-
$1.27 M(+17.6%)
Sept 2018
-
$1.08 M(-34.2%)
June 2018
$1.64 M(+25.6%)
$1.64 M(-18.6%)
Mar 2018
-
$2.01 M(-9.6%)
Dec 2017
-
$2.23 M(+46.0%)
Sept 2017
-
$1.53 M(+16.9%)
DateAnnualQuarterly
June 2017
$1.30 M(+107.9%)
$1.30 M(+28.0%)
Mar 2017
-
$1.02 M(+41.4%)
Dec 2016
-
$721.00 K(+49.5%)
Sept 2016
-
$482.30 K(-23.1%)
June 2016
$627.40 K(-26.5%)
$627.40 K(-7.2%)
Mar 2016
-
$676.00 K(+26.2%)
Dec 2015
-
$535.80 K(+30.2%)
Sept 2015
-
$411.50 K(-51.8%)
June 2015
$853.10 K(+184.5%)
$853.10 K(+61.1%)
Mar 2015
-
$529.70 K(+80.0%)
Dec 2014
-
$294.20 K(-12.4%)
Sept 2014
-
$335.70 K(-23.7%)
June 2014
$299.90 K(+20.2%)
-
Mar 2014
-
$440.20 K(+76.4%)
Dec 2013
$249.50 K(+2395.0%)
$249.50 K(-41.7%)
Sept 2013
-
$427.80 K(-35.9%)
June 2013
-
$667.70 K(-23.7%)
Mar 2013
-
$875.00 K(+4364.3%)
Dec 2012
-
$19.60 K(+50.8%)
Sept 2012
-
$13.00 K(+30.0%)
June 2012
-
$10.00 K(0.0%)
June 2012
$10.00 K(>+9900.0%)
-
Mar 2012
-
$10.00 K(+104.1%)
Dec 2011
-
$4900.00(>+9900.0%)
Sept 2011
-
$0.00(0.0%)
June 2011
$0.00(-100.0%)
$0.00(0.0%)
Mar 2011
-
$0.00(0.0%)
Dec 2010
-
$0.00(-100.0%)
June 2010
$700.00
$700.00

FAQ

  • What is Kintara Therapeutics annual total current liabilities?
  • What is the all time high annual current liabilities for Kintara Therapeutics?
  • What is Kintara Therapeutics annual current liabilities year-on-year change?
  • What is Kintara Therapeutics quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for Kintara Therapeutics?
  • What is Kintara Therapeutics quarterly current liabilities year-on-year change?

What is Kintara Therapeutics annual total current liabilities?

The current annual current liabilities of KTRA is $2.26 M

What is the all time high annual current liabilities for Kintara Therapeutics?

Kintara Therapeutics all-time high annual total current liabilities is $3.99 M

What is Kintara Therapeutics annual current liabilities year-on-year change?

Over the past year, KTRA annual total current liabilities has changed by -$823.00 K (-26.70%)

What is Kintara Therapeutics quarterly total current liabilities?

The current quarterly current liabilities of KTRA is $2.26 M

What is the all time high quarterly current liabilities for Kintara Therapeutics?

Kintara Therapeutics all-time high quarterly total current liabilities is $3.99 M

What is Kintara Therapeutics quarterly current liabilities year-on-year change?

Over the past year, KTRA quarterly total current liabilities has changed by -$1.08 M (-32.28%)